MyFinsight
Home
Blog
About
Proceeds from maturities
of marketable...
$70,566K
(-48.46%↓ Y/Y)
Stock-based compensation
$5,339K
(-60.22%↓ Y/Y)
Proceeds from sale of
property and equipment
$3K
(-94.64%↓ Y/Y)
Accrued expenses and
other liabilities
$4,117K
(514.48%↑ Y/Y)
Operating lease
liabilities
$2,082K
(194.77%↑ Y/Y)
Depreciation and
amortization
$2,009K
(-46.64%↓ Y/Y)
Trade accounts
receivable
-$1,971K
(72.24%↑ Y/Y)
Trade accounts
payable
$1,740K
(48.85%↑ Y/Y)
Other non-cash
expense (income), net
-$1,588K
Amortization of operating
lease-right-of use assets
$976K
(-53.68%↓ Y/Y)
Provision for excess and
obsolete inventory
$440K
(31.34%↑ Y/Y)
Loss on disposal of
property and equipment
-$138K
(45.45%↑ Y/Y)
Interest expenses for
accretion of the legal...
$86K
(-70.55%↓ Y/Y)
Provision for credit
losses
$54K
(3.85%↑ Y/Y)
Net cash (used in)
investing activities
$7,022K
(200.88%↑ Y/Y)
Net cash (used in)
operating activities
$1,367K
(8141.18%↑ Y/Y)
Canceled cashflow
$63,547K
Effect of exchange rate
changes on cash and cash...
$606K
(128.20%↑ Y/Y)
Canceled cashflow
$19,174K
Total revenue, net
$48,140K
Net (decrease) in
cash and cash...
$8,181K
(135.15%↑ Y/Y)
Canceled cashflow
$814K
Purchases of marketable
securities
-$61,303K
(56.65%↑ Y/Y)
Purchase of property and
equipment
$2,216K
(-8.66%↓ Y/Y)
Purchase of intangible
assets
$28K
(-63.16%↓ Y/Y)
Net loss
-$12,158K
(28.42%↑ Y/Y)
Inventories
$2,859K
(-43.64%↓ Y/Y)
Prepaid expenses and
other assets
$2,249K
(436.75%↑ Y/Y)
Gain on investments,
accretion, and...
-$1,298K
(58.24%↑ Y/Y)
Deferred revenue
-$400K
(-125.30%↓ Y/Y)
Legal settlement
liabilities
-$210K
(64.29%↑ Y/Y)
Proceeds from employee
stock purchase plan
$851K
(21.05%↑ Y/Y)
Proceeds from issuance of
common stock under...
$91K
(-11.65%↓ Y/Y)
Proceeds from line of
credit
$41K
(-98.02%↓ Y/Y)
Canceled cashflow
$48,140K
Net cash provided by
(used in) financing...
-$814K
(94.25%↑ Y/Y)
Canceled cashflow
$983K
Cost of sales
(excluding stock-based...
$18,584K
General and
administrative (excluding...
$14,088K
Sales (excluding
stock-based compensation)
$9,042K
Research and development
(excluding stock-based...
$8,649K
Stock-based compensation
expense
$5,339K
Marketing (excluding
stock-based compensation)
$3,358K
Other segment items
$757K
Amortization - license & ip
expense
$481K
Repayment of loan
$1,613K
(-2.83%↓ Y/Y)
Payments for taxes
related to net share...
$184K
(-20.35%↓ Y/Y)
Back
Back
Cash Flow
Cytek Biosciences, Inc. (CTKB)
Cytek Biosciences, Inc. (CTKB)
source: myfinsight.com